LGR5 marks targetable tumor-initiating cells in mouse liver cancer
Open Access
- 23 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 11 (1), 1-16
- https://doi.org/10.1038/s41467-020-15846-0
Abstract
Cancer stem cells (CSCs) or tumor-initiating cells (TICs) are thought to be the main drivers for disease progression and treatment resistance across various cancer types. Identifying and targeting these rare cancer cells, however, remains challenging with respect to therapeutic benefit. Here, we report the enrichment of LGR5 expressing cells, a well-recognized stem cell marker, in mouse liver tumors, and the upregulation of LGR5 expression in human hepatocellular carcinoma. Isolated LGR5 expressing cells from mouse liver tumors are superior in initiating organoids and forming tumors upon engraftment, featuring candidate TICs. These cells are resistant to conventional treatment including sorafenib and 5-FU. Importantly, LGR5 lineage ablation significantly inhibits organoid initiation and tumor growth. The combination of LGR5 ablation with 5-FU, but not sorafenib, further augments the therapeutic efficacy in vivo. Thus, we have identified the LGR5(+) compartment as an important TIC population, representing a viable therapeutic target for combating liver cancer. Cancer stem cells (CSCs) are thought to be the main drivers for disease progression and treatment resistance in liver cancer. This study identifies the LGR5+ compartment as an important CSC population, representing a viable therapeutic target for combating liver cancer.Funding Information
- KWF Kankerbestrijding (10140)
This publication has 45 references indexed in Scilit:
- Human primary liver cancer-derived organoid cultures for disease modeling and drug screeningNature Medicine, 2017
- A New View of Pathway-Driven Drug Resistance in Tumor ProliferationTrends in Pharmacological Sciences, 2017
- Targeting metastasis-initiating cells through the fatty acid receptor CD36Nature, 2016
- In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regenerationNature, 2013
- Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptorsNature, 2012
- The cancer stem cell: premises, promises and challengesNature Medicine, 2011
- The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signalingOncogene, 2011
- Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinomaHepatology, 2007
- Transcriptome classification of HCC is related to gene alterations and to new therapeutic targetsHepatology, 2006
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004